COCO Form 4: Michael Kirban Disposes 20,000 Shares Under 10b5-1 Plan
Rhea-AI Filing Summary
Michael Kirban, Executive Chairman and Director of Vita Coco Company, Inc. (COCO), reported a sale of common stock under a Rule 10b5-1 trading plan. On 09/11/2025 he disposed of 20,000 shares at a weighted average price of $39.045 (individual sale prices ranged from $39.00 to $39.19). After the reported transaction(s) the filing shows 1,579,049 shares beneficially owned indirectly by Mr. Kirban and additional holdings tied to the Michael Kirban Revocable Trust. The filing also discloses outstanding non-qualified stock options totaling 1,164,490 options across multiple grants with exercise prices ranging from $10.178 to $32.78 and varying vesting and expiration schedules. The sale was executed pursuant to a pre-established plan and the Form 4 was signed by an attorney-in-fact on 09/15/2025.
Positive
- Transaction executed under a Rule 10b5-1 plan, indicating the sale was pre-arranged
- Substantial beneficial ownership remains (1,579,049 shares reported indirectly)
- Extensive option holdings with staggered vesting support continued alignment with shareholders
Negative
- Insider sale of 20,000 shares reduces the reporting person’s economic stake
- Some options have exercise prices below current sale price, implying potential future dilution when exercised
Insights
TL;DR: Routine insider sale under a 10b5-1 plan, not an unexpected governance red flag.
The sale of 20,000 shares through a Rule 10b5-1 plan signals a pre-arranged disposition rather than a discretionary, contemporaneous insider trade. The filing confirms substantial indirect beneficial ownership remains with Mr. Kirban and his revocable trust, and multiple option grants remain outstanding with staggered vesting. From a governance perspective, disclosure is complete for the transactions and option holdings shown; there is no indication in the filing of undisclosed related-party or other governance concerns.
TL;DR: Insider sold a modest number of shares; material ownership and long-term incentive alignment remain.
The 20,000-share sale at about $39.05 is small relative to the reported indirect ownership of over 1.5 million shares and to the aggregate option positions. The presence of multiple vested and unvested option grants with exercise prices notably below and above the sale price provides continued potential equity exposure and retention incentives. The use of a 10b5-1 plan reduces timing concerns but investors may note the sale when modeling insider liquidity.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 20,000 | $39.045 | $781K |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.00 to $39.19, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These shares are held by the Michael Kirban Revocable Trust. The stock option is fully vested and currently exercisable. The stock option is fully vested and currently exercisable. The stock option vests in four equal annual installments beginning on November 27, 2022. The stock option vests in four equal annual installments beginning on March 10, 2024. The stock option vests in four equal annual installments beginning on March 4, 2025. The Stock Option vests in four equal annual installments beginning in March 3, 2026.
